Tycho Peterson's questions to Thermo Fisher Scientific Inc (TMO) leadership • Q3 2024
Question
Tycho Peterson asked for more detail on the drivers within the Laboratory Products and Biopharma Services segment, including channel share gains and the performance of PPD and Patheon. He also inquired about the pricing environment and plans for Patheon's capacity expansion.
Answer
CFO Stephen Williamson confirmed that strong underlying growth in Pharma Services and clinical research offset pandemic headwinds. CEO Marc Casper added that the research and healthcare channels are performing well and winning new customers. Regarding pricing, Williamson noted it was just over 1% for the company. Casper described the pricing environment as 'back to normal' and confirmed ongoing investments in sterile fill finish capacity set to come online in 2025-2026.